-
Liquid biopsy for breast cancer and other solid tumors: a review of recent advances Breast Cancer (IF 4.0) Pub Date : 2024-03-16
Abstract Liquid biopsy using circulating tumor DNA (ctDNA) has been reported to be less invasive and effective for comprehensive genetic analysis of heterogeneous solid tumors, including decision-making for therapeutic strategies, predicting recurrence, and detecting genetic factors related to treatment resistance in various types of cancers. Breast cancer, colorectal cancer, and lung cancer are among
-
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-03-14 Xue Hu
-
Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB Breast Cancer (IF 4.0) Pub Date : 2024-03-12 Guo Li, Xinyue Lin, Xinpeng Wang, Lvjuan Cai, Jianren Liu, Yunyun Zhu, Zhichao Fu
-
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile Breast Cancer (IF 4.0) Pub Date : 2024-03-12 Danbee Kang, Seri Park, Hyo Jung Kim, Jiseon Lee, Jiyoon Han, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Ji-Yeon Kim, Seok Jin Nam, Juhee Cho, Yeon Hee Park
Background In recognition of the distinct clinical challenges and research gaps in young breast cancer (YBC) patients, we established the Comprehensive Young Age Breast Cancer (CHARM) registry to collect prospective data. Methods This prospective cohort included patients who were newly diagnosed with histologically confirmed breast cancer without prior treatment at the Samsung Medical Center (SMC)
-
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-03-08
Abstract Background Characteristics of taxane-induced peripheral neuropathy (PN) could be different between paclitaxel and nab-paclitaxel. The purpose of this prospective observational multicenter cohort study was to compare tri-weekly nab-paclitaxel to weekly standard paclitaxel regarding the severity, onset and recovery of sensory and motor PN in patients with breast cancer. Methods Patients with
-
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan Breast Cancer (IF 4.0) Pub Date : 2024-03-07 Yasue Tsuchida, Naoki Niikura, Takashi Chishima, Mari Mizuno, Takahiko Kawate, Hiromi Fuchikami, Yasuo Miyoshi, Takehiko Sakai, Haruru Kotani, Naoto Kondo, Naoki Hayashi
-
Deep learning model to predict Ki-67 expression of breast cancer using digital breast tomosynthesis Breast Cancer (IF 4.0) Pub Date : 2024-03-07 Ken Oba, Maki Adachi, Tomoya Kobayashi, Eichi Takaya, Daiki Shimokawa, Toshinori Fukuda, Kengo Takahashi, Kazuyo Yagishita, Takuya Ueda, Hiroko Tsunoda
-
Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Breast Cancer (IF 4.0) Pub Date : 2024-03-04 Reiko Fukui, Takahiro Watanabe, Koji Morimoto, Yukie Fujimoto, Masayuki Nagahashi, Eri Ishikawa, Seiichi Hirota, Yasuo Miyoshi
-
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines Breast Cancer (IF 4.0) Pub Date : 2024-03-04 Masaya Hattori, Naoko Honma, Shigenori Nagai, Kazutaka Narui, Tomoko Shigechi, Yukinori Ozaki, Masayuki Yoshida, Takashi Sakatani, Eiichi Sasaki, Yuko Tanabe, Junji Tsurutani, Toshimi Takano, Shigehira Saji, Shinobu Masuda, Rie Horii, Hitoshi Tsuda, Rin Yamaguchi, Tatsuya Toyama, Chikako Yamauchi, Masakazu Toi, Yutaka Yamamoto
The Japanese Breast Cancer Society Clinical Practice Guidelines are published as timely guidance on clinical issues in breast cancer treatment in Japan. In the recent edition of these guidelines, we addressed a new clinical question 34 (CQ 34, systemic treatment part) “Is trastuzumab deruxtecan recommended for patients with unresectable or metastatic HER2-low breast cancer?” and a new future research
-
SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β Breast Cancer (IF 4.0) Pub Date : 2024-02-29 Monalisa Parija, Surya Prakash, B. Madhu Krishna, Sanghamitra Dash, Sandip K. Mishra
-
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Breast Cancer (IF 4.0) Pub Date : 2024-02-18 Nalee Kim, Won Kyung Cho, Won Park, Jeong Eon Lee, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Sei Kyung Lee, Jai-Min Ryu, Eun Sook Ko, Haeyoung Kim
-
Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-02-15 Kazuhiko Sato, Hiromi Fuchikami, Naoko Takeda, Nana Natsume, Masahiro Kato
-
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-02-13 Sean M. Hacking, Gabrielle Windsor, Robert Cooper, Zhicheng Jiao, Ana Lourenco, Yihong Wang
-
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy Breast Cancer (IF 4.0) Pub Date : 2024-02-07 Mikiko Kasahara, Sayaka Kanematsu, Yoshihito Tanaka, Satoshi Okazaki, Masahiro Watatani
-
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry Breast Cancer (IF 4.0) Pub Date : 2024-02-06 Takayuki Iwamoto, Hiraku Kumamaru, Naoki Niikura, Yasuaki Sagara, Minoru Miyashita, Takaaki Konishi, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Chie Watanabe, Naoko Kinukawa, Masakazu Toi, Shigehira Saji
-
Advances in the study of autophagy in breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-02-05 Tang Yu, Liu Rui, Zhao Jiumei, Li Ziwei, Hu Ying
-
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-02-04
Abstract Background Long non-coding RNAs (lncRNAs) have been found to play important roles in occurrence, development, and metastasis of various tumors. We aimed to screen long non-coding RNAs (lncRNAs) that promote invasion and metastasis of breast cancer cells under hypoxia, and investigate the relationship between lncRNA expression and clinicopathological features and prognosis in invasive breast
-
Patient-reported outcomes of mesh in minimally invasive (laparoscopic/robot-assisted) immediate subpectoral prosthesis breast reconstruction: a retrospective study Breast Cancer (IF 4.0) Pub Date : 2024-02-02
Abstract Background Although there is increasing interest in minimally invasive prosthesis breast reconstruction (PBR), whether meshes application in minimally invasive PBR can improve complications and cosmetic effects remains controversial. The author retrospectively analyzed postoperative complications and evaluated patient-reported quality-of-life outcomes in minimally invasive PBR with and without
-
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models Breast Cancer (IF 4.0) Pub Date : 2024-01-30 Hongyan Zheng, Lihua Wu, Jianfeng Chen, Na Na, Ge Lou
-
Endosomal protein expression of γ1-adaptin is associated with tumor growth activity and relapse-free survival in breast cancer Breast Cancer (IF 4.0) Pub Date : 2024-01-24
Abstract Background γ1-Adaptin is a subunit of adaptor protein complex-1 (AP-1), which regulates intracellular transport between the trans-Golgi network (TGN) and endosomes. Since expression levels of AP-1 subunits have been reported to be associated with cell proliferation and cancer malignancy, we investigated the relationships between the immunohistochemical expression of γ1-adaptin and both clinicopathological
-
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes Breast Cancer (IF 4.0) Pub Date : 2024-01-17 Wu Ding, Dengfeng Ye, Haifeng Chen, Yingli Lin, Zhian Li, Chuanjian Tu
-
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan Breast Cancer (IF 4.0) Pub Date : 2024-01-05 Yasuaki Sagara, Hiraku Kumamaru, Naoki Niikura, Minoru Miyashita, Takaaki Konishi, Takayuki Iwamoto, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Naoko Kinukawa, Chie Watanabe, Masakazu Toi, Shigehira Saji
-
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy Breast Cancer (IF 4.0) Pub Date : 2024-01-04 Naruto Taira, Yuichiro Kikawa, Takayuki Iwamoto, Yuichiro Miyoshi, Kyoko Hara, Seiji Yoshitomi, Hajime Hikino, Hirotoshi Takahashi, Daisuke Takabatake, Shinichiro Kubo, Masahiko Ikeda, Hiroyoshi Doihara, Tadahiko Shien, Hiromi Okuyama, Yuko Tanabe, Fumikata Hara, Kosho Yamanouchi, Yasuhiro Hagiwara, Masataka Sawaki
-
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole Breast Cancer (IF 4.0) Pub Date : 2024-01-01 Masato Takahashi, Tomofumi Osako, Hiroyuki Yasojima, Kenichi Inoue, Masahiro Kawashima, Hideki Maeda, Akemi Ichikawa, Yasuaki Muramatsu, Norikazu Masuda
-
The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience Breast Cancer (IF 4.0) Pub Date : 2023-12-27 Yi-Wen Hong, I-Ming Kuo, Wen-Ling Kuo, Chi-Chang Yu, Shih-Che Shen, Hsiu-Pei Tsai, Chia-Hui Chu, Hui-Yu Ho, Yung-Feng Lo, Shin-Cheh Chen, Yung-Chang Lin, Chih-Ying Chien, Hsu-Huan Chou
-
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition Breast Cancer (IF 4.0) Pub Date : 2023-12-26 Masaaki Kawai, Shoichiro Ohtani, Motoki Iwasaki, Seiichiro Yamamoto, Kiyoshi Takamatsu, Hitoshi Okamura, Masami Arai, Tsunehisa Nomura, Shinji Ozaki, Ken-ichi Shibata, Ayaka Akabane, Fuyuhiko Motoi, Chikako Yamauchi, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji
-
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre Breast Cancer (IF 4.0) Pub Date : 2023-12-26 Han Hsi Wong, Elena Cojocaru, James Watkins, Sujil James, Tony Aloysius, Jennifer Harrington, Gail Horan, Helen Hatcher
-
Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence Breast Cancer (IF 4.0) Pub Date : 2023-12-22
Abstract Background Metastatic spread is characterized by considerable heterogeneity in most cancers. With increasing treatment options for patients with metastatic disease, there is a need for insight into metastatic patterns of spread in breast cancer patients using large-scale studies. Methods Records of 2622 metastatic breast cancer patients who underwent autopsy (1974–2010) were retrieved from
-
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale Breast Cancer (IF 4.0) Pub Date : 2023-12-11 Yosuke Aoyama, Eri Hoshino, Akihiko Shimomura, Chikako Shimizu, Tomoko Taniyama, Manami Tada, Nao Yoshida, Hitomi Sato, Kiyomi Nonogaki, Kazumasa Yamamoto, Taro Yamanaka, Rika Kizawa, Takeshi Yamaguchi, Kiyo Tanaka, Yoko Kobayashi, Nobuko Tamura, Yuko Tanabe, Yuji Miura, Yuichiro Kikawa, Juhee Cho, Hidetaka Kawabata
-
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan Breast Cancer (IF 4.0) Pub Date : 2023-12-09 Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I. Lai, Ling-Ming Tseng, Chi-Cheng Huang
-
Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database Breast Cancer (IF 4.0) Pub Date : 2023-12-03 Zhenning Tang, Ling Li, Xiaoying Huang, Yinbing Zhao, Lingyan Huang
-
Annual report of the Japanese Breast Cancer Registry for 2019 Breast Cancer (IF 4.0) Pub Date : 2023-12-04 Minoru Miyashita, Hiraku Kumamaru, Naoki Niikura, Yasuaki Sagara, Takaaki Konishi, Takayuki Iwamoto, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Chie Watanabe, Naoko Kinukawa, Masakazu Toi, Shigehira Saji
-
The effects of breast density on the benefits of mammograms with adjunctive ultrasonography in breast screening Breast Cancer (IF 4.0) Pub Date : 2023-11-28 Akira Nakamura, Koji Ohnuki, Haruka Takahashi, Shin Usami, Yuki Ishida, Setsuko Shibata, Akiko Umemura, Yuka Takikawa, Atsushi Kano
Objective Various efforts have been made to improve the accuracy of breast cancer screening. This study aimed to report differences in the contribution of ultrasonography to cancer screening assessments of dense and non-dense breasts. Methods The participants in this study were 29,640 Japanese women in their 40 s who underwent breast cancer screening at the Iwate Cancer Society between 2018 and 2021
-
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer Breast Cancer (IF 4.0) Pub Date : 2023-11-23 Asumi Iesato, Atsushi Fushimi, Rie Tahara, Mitsuo Terada, Madoka Iwase, Chihiro Kawamura, Nami Yamashita
-
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan Breast Cancer (IF 4.0) Pub Date : 2023-11-20 Yoshitaka Nishikawa, Nobukazu Agatsuma, Takahiro Utsumi, Taro Funakoshi, Yukiko Mori, Yuki Nakamura, Nobuaki Hoshino, Takahiro Horimatsu, Takumi Saito, Soichiro Kashihara, Jun Fukuyoshi, Rei Goto, Masakazu Toi, Yoshimitsu Takahashi, Takeo Nakayama
-
IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G Breast Cancer (IF 4.0) Pub Date : 2023-11-19 Rui Jing, Shukun Bai, Peipei Zhang, Hao Ren, Lintao Jia, Weimiao Li, Guoxu Zheng
-
Comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Breast Cancer (IF 4.0) Pub Date : 2023-11-20 Yoshiya Horimoto
This is a comment on the article by Fukui et al. investigating the relationship between tumor-infiltrating lymphocytes (TILs) and response to neoadjuvant endocrine therapy in estrogen receptor-positive/HER2-negative breast cancer. While their data are quite interesting, some information crucial for interpreting the results of this study is missing. Therefore, I would like the authors to provide additional
-
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels Breast Cancer (IF 4.0) Pub Date : 2023-11-16 Amira Fathy, Mohamed A. Abdelrazek, Abdelfattah M. Attallah, Amr Abouzid, Mohamed El-Far
-
The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition Breast Cancer (IF 4.0) Pub Date : 2023-11-16 Kazunori Kubota, Kazutaka Nakashima, Kazuaki Nakashima, Masako Kataoka, Kenich Inoue, Mariko Goto, Chizuko Kanbayashi, Koichi Hirokaga, Ken Yamaguchi, Akihiko Suzuki
This article provides updates to readers based on the newly published Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2022 Edition. These guidelines incorporate the latest evaluation of evidence from studies of diagnostic accuracy. For each clinical question, outcomes for benefits and harms were established, and qualitative or quantitative systematic
-
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study Breast Cancer (IF 4.0) Pub Date : 2023-11-15 Florian Pelzer, Wilfried Tröger, Marcus Reif, Susanne Schönberg, David D. Martin, Cornelia Müller, Isabell Utz-Billing, Thorsten Kühn, Stephan Baumgartner, Marion Kiechle, Daniela Paepke
Background Few measurements of fatigue and quality of life have been performed during neoadjuvant chemotherapy of early breast cancer. This study evaluates fatigue and quality of life experienced by early breast cancer patients during neoadjuvant chemotherapy and their association with different clinical parameters. Methods Fifty-four stage I–III patients’ responses to the Multidimensional Fatigue
-
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer Breast Cancer (IF 4.0) Pub Date : 2023-11-08 Helle Pappot, Benóný P. Björnsson, Oswin Krause, Christina Bæksted, Pernille E. Bidstrup, Susanne O. Dalton, Christoffer Johansen, Ann Knoop, Ivan Vogelius, Cecilie Holländer-Mieritz
-
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer Breast Cancer (IF 4.0) Pub Date : 2023-11-02 Xiaowei Shen, Ganggang Wang, Hua He, Ping Shang, Bin Yan, Xiaoliang Wang, Weixing Shen
-
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy Breast Cancer (IF 4.0) Pub Date : 2023-11-01 Mellissa Williamson, David J. Press, Svenn Alexander Hansen, Akanksha Tomar, Gurleen Singh Jhuti, Cedric Revil, Kaustubh Gururaj
-
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study Breast Cancer (IF 4.0) Pub Date : 2023-10-21 Masahiro Yoshida, Ryo-ichi Yoshimura, Ryoichi Notake, Hidenori Shinjo, Kazunori Miyaura, Takashi Kuwayama, Takashi Kawanaka, Tadahiko Shien, Kotaro Yoshio, Toshiko Shiga, Yuko Kaneyasu, Tsuyoshi Nakagawa, Kazunori Kubota, Seigo Nakamura, Jun Itami
-
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition Breast Cancer (IF 4.0) Pub Date : 2023-10-16 Takehiko Sakai, Goro Kutomi, Tadahiko Shien, Sota Asaga, Tomoyuki Aruga, Makoto Ishitobi, Sayaka Kuba, Masataka Sawaki, Kaori Terata, Koichi Tomita, Chikako Yamauchi, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji
The 2022 revision of the Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for surgical treatment of breast cancer was updated following a systematic review of the literature using the Medical Information Network Distribution Service (MINDS) procedure, which focuses on the balance of benefits and harms for various clinical questions (CQs). Experts in surgery designated by the JBCS
-
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study Breast Cancer (IF 4.0) Pub Date : 2023-10-13 Linghui Kong, Zhen Yang, Chen Zheng, Tingting Lu, Huijun Zhang
-
Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography Breast Cancer (IF 4.0) Pub Date : 2023-10-12 Takayoshi Uematsu
-
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer Breast Cancer (IF 4.0) Pub Date : 2023-10-09 Yoshitaka Fujiki, Masahiro Kashiwaba, Mutsumi Sato, Junko Kawano, Megumi Teraoka, Shuichi Kanemitsu, Yoshiaki Rai, Tetsuhiko Taira, Yoshiaki Sagara, Yasuyo Ohi, Uiree Jo, Young-Won Lee, Sae Byul Lee, Gyungyub Gong, Young Kee Shin, Mi Jeong Kwon, Yasuaki Sagara
-
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition Breast Cancer (IF 4.0) Pub Date : 2023-10-07 Mitsuo Terada, Aki Ito, Yuichiro Kikawa, Kei Koizumi, Yoichi Naito, Tatsunori Shimoi, Mikiya Ishihara, Takashi Yamanaka, Yukinori Ozaki, Fumikata Hara, Rikiya Nakamura, Masaya Hattori, Minoru Miyashita, Naoto Kondo, Tetsuhiro Yoshinami, Masahiro Takada, Koji Matsumoto, Kazukata Narui, Shinsuke Sasada, Takayuki Iwamoto, Mitsuchika Hosoda, Yuko Takano, Takaaki Oba, Hitomi Sakai, Akari Murakami, Toru
The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer were updated to the 2022 edition through a process started in 2018. The updated guidelines consist of 12 background questions (BQs), 33 clinical questions (CQs), and 20 future research questions (FRQs). Multiple outcomes including efficacy and safety were selected in each CQ, and then quantitative
-
Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer Breast Cancer (IF 4.0) Pub Date : 2023-10-04 Kazushi Suzuki, Rintaro Ohe, Takanobu Kabasawa, Takumi Kitaoka, Masaaki Kawai, Fuyuhiko Motoi, Mitsuru Futakuchi
-
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer Breast Cancer (IF 4.0) Pub Date : 2023-10-02 Hiroki Kusama, Nobuyoshi Kittaka, Ai Soma, Azusa Taniguchi, Haruka Kanaoka, Satomi Nakajima, Yuri Oyama, Yukiko Seto, Jun Okuno, Noriyuki Watanabe, Saki Matsui, Minako Nishio, Fumie Fujisawa, Keiichiro Honma, Yasuhiro Tamaki, Takahiro Nakayama
-
Preparation, characterization, and in vitro cytotoxicity activity of allyl-isothiocyanate-embedded polymeric nanoparticles for potential breast cancer targeting Breast Cancer (IF 4.0) Pub Date : 2023-09-11 Prashant Bhagwan Patil, Jayvadan Kantilal Patel
-
Glutaminase (GLS1) gene expression in primary breast cancer Breast Cancer (IF 4.0) Pub Date : 2023-09-07 Neelima Vidula, Christina Yau, Hope S. Rugo
-
Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis Breast Cancer (IF 4.0) Pub Date : 2023-08-31 Huaying Dong, Changcheng Yang, Xiang Chen, Hening Sun, Xionghui He, Wei Wang
-
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes Breast Cancer (IF 4.0) Pub Date : 2023-08-29 Fumiaki Sanuki, Yuka Mikami, Hirotake Nishimura, Yoshinori Fujita, Yasumasa Monobe, Tsunehisa Nomura, Naruto Taira, Takuya Moriya
-
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images Breast Cancer (IF 4.0) Pub Date : 2023-08-27 Tomoki Imokawa, Yoko Satoh, Tomoyuki Fujioka, Kanae Takahashi, Mio Mori, Kazunori Kubota, Hiroshi Onishi, Ukihide Tateishi
-
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer Breast Cancer (IF 4.0) Pub Date : 2023-08-23 Takeshi Murata, Masayuki Yoshida, Sho Shiino, Chikashi Watase, Ayumi Ogawa, Shohei Shikata, Hiromi Hashiguchi, Yukiko Yoshii, Hirokazu Sugino, Kenjiro Jimbo, Akiko Maeshima, Eriko Iwamoto, Shin Takayama, Akihiko Suto
-
Ex vivo dual gene therapy using human adipocytes secreting anti-HER2 antibody on HER2-positive xenograft tumor models Breast Cancer (IF 4.0) Pub Date : 2023-08-23 Ryotaro Teranaka, Hiroshi Fujimoto, Takahito Masuda, Masayuki Kuroda, Yasuyuki Aoyagi, Takeshi Nagashima, Mamoru Takada, Junta Sakakibara, Hideyuki Yamada, Hiroto Yamamoto, Yoshitaka Kubota, Masayuki Ohtsuka
-
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data Breast Cancer (IF 4.0) Pub Date : 2023-08-16 Shiao Li Oei, Anja Thronicke, Gerrit Grieb, Friedemann Schad, Jessica Groß
-
MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis Breast Cancer (IF 4.0) Pub Date : 2023-08-14 R. L. Akshaya, I. Saranya, N. Selvamurugan